PMID- 23712092 OWN - NLM STAT- MEDLINE DCOM- 20141121 LR - 20221207 IS - 1473-1150 (Electronic) IS - 1470-269X (Print) IS - 1470-269X (Linking) VI - 14 IP - 2 DP - 2014 Apr TI - HIBAG--HLA genotype imputation with attribute bagging. PG - 192-200 LID - 10.1038/tpj.2013.18 [doi] AB - Genotyping of classical human leukocyte antigen (HLA) alleles is an essential tool in the analysis of diseases and adverse drug reactions with associations mapping to the major histocompatibility complex (MHC). However, deriving high-resolution HLA types subsequent to whole-genome single-nucleotide polymorphism (SNP) typing or sequencing is often cost prohibitive for large samples. An alternative approach takes advantage of the extended haplotype structure within the MHC to predict HLA alleles using dense SNP genotypes, such as those available from genome-wide SNP panels. Current methods for HLA imputation are difficult to apply or may require the user to have access to large training data sets with SNP and HLA types. We propose HIBAG, HLA Imputation using attribute BAGging, that makes predictions by averaging HLA-type posterior probabilities over an ensemble of classifiers built on bootstrap samples. We assess the performance of HIBAG using our study data (n=2668 subjects of European ancestry) as a training set and HLA data from the British 1958 birth cohort study (n approximately 1000 subjects) as independent validation samples. Prediction accuracies for HLA-A, B, C, DRB1 and DQB1 range from 92.2% to 98.1% using a set of SNP markers common to the Illumina 1M Duo, OmniQuad, OmniExpress, 660K and 550K platforms. HIBAG performed well compared with the other two leading methods, HLA*IMP and BEAGLE. This method is implemented in a freely available HIBAG R package that includes pre-fit classifiers for European, Asian, Hispanic and African ancestries, providing a readily available imputation approach without the need to have access to large training data sets. FAU - Zheng, X AU - Zheng X AD - Department of Biostatistics, University of Washington, Seattle, WA, USA. FAU - Shen, J AU - Shen J AD - Quantitative Sciences, GlaxoSmithKline, Research Triangle Park, NC, USA. FAU - Cox, C AU - Cox C AD - Quantitative Sciences, GlaxoSmithKline, Stevenage, UK. FAU - Wakefield, J C AU - Wakefield JC AD - Department of Biostatistics, University of Washington, Seattle, WA, USA. FAU - Ehm, M G AU - Ehm MG AD - Quantitative Sciences, GlaxoSmithKline, Research Triangle Park, NC, USA. FAU - Nelson, M R AU - Nelson MR AD - Quantitative Sciences, GlaxoSmithKline, Research Triangle Park, NC, USA. FAU - Weir, B S AU - Weir BS AD - Department of Biostatistics, University of Washington, Seattle, WA, USA. LA - eng GR - Wellcome Trust/United Kingdom GR - G1001799/MRC_/Medical Research Council/United Kingdom GR - R01 GM075091/GM/NIGMS NIH HHS/United States GR - GM 75091/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130528 PL - United States TA - Pharmacogenomics J JT - The pharmacogenomics journal JID - 101083949 RN - 0 (HLA Antigens) SB - IM MH - Alleles MH - Asian People/genetics MH - Drug-Related Side Effects and Adverse Reactions/*genetics MH - Genome-Wide Association Study MH - Genotype MH - HLA Antigens/*genetics MH - Haplotypes MH - Humans MH - Major Histocompatibility Complex/*genetics MH - Polymorphism, Single Nucleotide MH - White People/genetics PMC - PMC3772955 MID - NIHMS457572 EDAT- 2013/05/29 06:00 MHDA- 2014/12/15 06:00 CRDT- 2013/05/29 06:00 PHST- 2012/08/08 00:00 [received] PHST- 2013/02/15 00:00 [revised] PHST- 2013/03/18 00:00 [accepted] PHST- 2013/05/29 06:00 [entrez] PHST- 2013/05/29 06:00 [pubmed] PHST- 2014/12/15 06:00 [medline] AID - tpj201318 [pii] AID - 10.1038/tpj.2013.18 [doi] PST - ppublish SO - Pharmacogenomics J. 2014 Apr;14(2):192-200. doi: 10.1038/tpj.2013.18. Epub 2013 May 28.